载有骨形态发生蛋白-2的甘草次酸-聚（乙二醇）-b-聚（L-赖氨酸）纳米颗粒的体外和体内蛋白质释放及抗缺血/再灌注损伤特性[撤回]
In vitro and in vivo Protein Release and Anti-Ischemia/Reperfusion Injury Properties of Bone Morphogenetic Protein-2-Loaded Glycyrrhetinic Acid-Poly(Ethylene Glycol)-b-Poly(L-Lysine) Nanoparticles [Retraction].
出版信息
Int J Nanomedicine. 2022 Jun 10;17:2609-2610. doi: 10.2147/IJN.S377806. eCollection 2022.
Abstract
[This retracts the article DOI: 10.2147/IJN.S146546.].
摘要
[本文撤回文章DOI: 10.2147/IJN.S146546。]
相似文献
1
In vitro and in vivo Protein Release and Anti-Ischemia/Reperfusion Injury Properties of Bone Morphogenetic Protein-2-Loaded Glycyrrhetinic Acid-Poly(Ethylene Glycol)-b-Poly(L-Lysine) Nanoparticles [Retraction].载有骨形态发生蛋白-2的甘草次酸-聚（乙二醇）-b-聚（L-赖氨酸）纳米颗粒的体外和体内蛋白质释放及抗缺血/再灌注损伤特性[撤回]
Int J Nanomedicine. 2022 Jun 10;17:2609-2610. doi: 10.2147/IJN.S377806. eCollection 2022.
2
In vitro and in vivo protein release and anti-ischemia/reperfusion injury properties of bone morphogenetic protein-2-loaded glycyrrhetinic acid-poly(ethylene glycol)-b-poly(l-lysine) nanoparticles.载骨形态发生蛋白 2 的甘草次酸-聚乙二醇-b-聚赖氨酸纳米粒的体外和体内蛋白释放及抗缺血/再灌注损伤特性。
Int J Nanomedicine. 2017 Oct 17;12:7613-7625. doi: 10.2147/IJN.S146546. eCollection 2017.
3
Poly (Ethylene Glycol)-Block-Brush Poly (L-Lysine) Copolymer as an Efficient Nanocarrier for Human Hepatocyte Growth Factor with Enhanced Bioavailability and Anti-Ischemia Reperfusion Injury Efficacy.聚（乙二醇）-嵌段-刷状聚（L-赖氨酸）共聚物作为人肝细胞生长因子的高效纳米载体，具有增强的生物利用度和抗缺血再灌注损伤功效。
Kidney Blood Press Res. 2017;42(3):495-508. doi: 10.1159/000479642. Epub 2017 Aug 30.
4
The effect of insulin-loaded linear poly(ethylene glycol)-brush-like poly(l-lysine) block copolymer on renal ischemia/reperfusion-induced lung injury through downregulating hypoxia-inducible factor.负载胰岛素的线性聚乙二醇刷状聚（L-赖氨酸）嵌段共聚物通过下调缺氧诱导因子对肾缺血/再灌注诱导的肺损伤的影响
Int J Nanomedicine. 2016 Apr 27;11:1717-30. doi: 10.2147/IJN.S99890. eCollection 2016.
5
Erythrocyte Membrane-Enveloped Salvianolic Acid B Nanoparticles Attenuate Cerebral Ischemia-Reperfusion Injury [Retraction].红细胞膜包被的丹酚酸B纳米粒减轻脑缺血再灌注损伤[撤回]
Int J Nanomedicine. 2022 Oct 5;17:4721-4722. doi: 10.2147/IJN.S392089. eCollection 2022.
6
PEG--(PELG--PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications.聚乙二醇-（聚乙交酯-左旋聚乳酸）纳米颗粒作为肿瘤坏死因子-α纳米载体：潜在的脑缺血/再灌注损伤治疗应用
Int J Nanomedicine. 2017 Mar 23;12:2243-2254. doi: 10.2147/IJN.S130842. eCollection 2017.
7
In vitro/vivo Drug Release and Anti-Diabetic Cardiomyopathy Properties of Curcumin/PBLG-PEG-PBLG Nanoparticles [Retraction].姜黄素/PBLG-PEG-PBLG纳米颗粒的体外/体内药物释放及抗糖尿病心肌病特性[撤回]
Int J Nanomedicine. 2021 May 25;16:3579. doi: 10.2147/IJN.S320050. eCollection 2021.
8
9
Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.甘草次酸修饰的壳聚糖/聚乙二醇纳米粒用于肝靶向递药。
Biomaterials. 2010 Jun;31(17):4748-56. doi: 10.1016/j.biomaterials.2010.02.042. Epub 2010 Mar 19.
10
Pharmacological Signatures of the Exenatide Nanoparticles Complex Against Myocardial Ischemia Reperfusion Injury.艾塞那肽纳米颗粒复合物抗心肌缺血再灌注损伤的药理特征
Kidney Blood Press Res. 2018;43(4):1273-1284. doi: 10.1159/000492409. Epub 2018 Aug 3.
Zotero 插件